Ethnic Differences in Response to Fluoxetine in a Controlled Trial With Depressed HIV-Positive Patients
- 1 February 1998
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 49 (2) , 239-240
- https://doi.org/10.1176/ps.49.2.239
Abstract
This study examined ethnic differences in response to antidepressant treatment. One hundred eighteen depressed HIV-positive patients entered an eight-week controlled trial of fluoxetine. Nineteen percent were black and 14 percent were Latino; the remaining two-thirds were white. Attrition was greater among Latinos than either blacks or whites. Black patients were more likely than whites to be nonresponders to fluoxetine. Latinos were more likely to respond to placebo compared with blacks and whites. Ethnic groups did not differ in the presence of treatment-emergent side effects.Keywords
This publication has 8 references indexed in Scilit:
- An Open-Label Study of SSRI Treatment in Depressed Hispanic and Non-Hispanic WomenThe Journal of Clinical Psychiatry, 1997
- A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patientsComprehensive Psychiatry, 1996
- Brain MR imaging findings in two patients with Alpers' syndromeClinical Imaging, 1996
- Cross-Cukural Aspects of the Somatization TraitPsychiatric Services, 1987
- The Brief Symptom Inventory: an introductory reportPsychological Medicine, 1983
- Pharmacotherapy of Hispanic Depressed Patients: Clinical ObservationsAmerican Journal of Psychotherapy, 1982
- Antidepressants in Black and White InpatientsArchives of General Psychiatry, 1975
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967